paclitaxel has been researched along with Hydatidiform Mole in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (50.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bae, SN; Jung, SG; Kim, CJ; Kim, SJ; Lee, C; Na, YJ | 1 |
Haller, U; Koechli, OR; Perras, JP; Rodriguez, M; Schaer, GN; Schenk, V; Sevin, BU; Steren, A; Untch, M | 1 |
2 other study(ies) available for paclitaxel and Hydatidiform Mole
Article | Year |
---|---|
Management of high-risk hydatidiform mole and persistent gestational trophoblastic neoplasia: the Korean experience.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Case-Control Studies; Cisplatin; Dactinomycin; Etoposide; Female; Humans; Hydatidiform Mole; Korea; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Paclitaxel; Pregnancy; Prospective Studies; Registries; Retrospective Studies; Risk Factors; Salvage Therapy; Severity of Illness Index; Uterine Neoplasms | 2007 |
In vitro chemosensitivity of paclitaxel and other chemotherapeutic agents in malignant gestational trophoblastic neoplasms.
Topics: Adenosine Triphosphate; Adult; Antineoplastic Agents; Choriocarcinoma; Dose-Response Relationship, Drug; Drug Resistance; Drug Screening Assays, Antitumor; Etoposide; Female; Humans; Hydatidiform Mole; Paclitaxel; Pregnancy; Trophoblastic Neoplasms; Tumor Cells, Cultured; Uterine Neoplasms; Vincristine | 1995 |